Pear Therapeutics, Inc.

Pear Therapeutics, Inc., is a healthcare business that is currently in the commercial stage and specializes in the fabrication and sales of computer-run medications. It offers reSET, an intervention designed to help people who have a dependency on substances including booze, cannabis, cocaine, and stimulants; reSET-O, one to treat opioid use disorder used in tandem with buprenorphine; and Somryst, which is a software-based treatment for chronic insomnia. Pear Therapeutics, Inc., established in 2013 with a headquarters in Boston, MA, is actively moving ahead with a range of 14 product candidates centered around psychiatry, neurology, and other non-CNS jurisdictions such as gastrointestinal, cancer, and cardiovascular.